- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Mercia Pharma Inc.
Total 3320 results
-
Thomas Martin, MDUniversity of California, Davis; Actavis Inc.; Eugia Pharma Specialities LimitedActive, not recruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Association des Médecins Vasculaires HospitaliersSanofi; Ministry of Health, France; Daiichi Sankyo, Inc.; LEO Pharma; University...CompletedCardiovascular Diseases | Venous Thromboembolism | Post Thrombotic SyndromeFrance
-
Sabine Mueller, MD, PhDPacific Pediatric Neuro-Oncology Consortium; Midatech Pharma US Inc.CompletedDiffuse Intrinsic Pontine GliomaUnited States
-
Pfizer's Upjohn has merged with Mylan to form Viatris...Aurobindo Pharma Ltd; Trident Life Sciences Ltd.Completed
-
Micell TechnologiesHefei Life Science Medical Instruments Co. Ltd.; Giant Med-Pharma Services... and other collaboratorsUnknownCoronary Heart DiseaseChina
-
Adhera Health, Inc.Hospital Miguel Servet; Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...CompletedEmotional Adjustment | Mood DisturbanceSpain
-
Peloton Therapeutics, Inc., a subsidiary of Merck...National Institutes of Health (NIH)CompletedClear Cell Renal Cell Carcinoma | Von Hippel-Lindau Disease | Clear Cell RCC | ccRCC | VHL Gene Mutation | VHL Syndrome | VHL Gene Inactivation | VHL | Von Hippel | Von Hippel's Disease | Von Hippel-Lindau Syndrome, Modifiers ofUnited States
-
Livzon Pharmaceutical Group Inc.Simoon Record Pharma Information Consulting Co., Ltd.; Guangdong Center for...Completed
-
Pfizer's Upjohn has merged with Mylan to form Viatris...Aurobindo Pharma Ltd; Trident Life Sciences Ltd.Completed
-
Asan Medical CenterSamsung Medical Center; Astellas Pharma Korea, Inc.; Severance Hospital; Kyung...CompletedType 2 Diabetes MellitusKorea, Republic of
-
San Francisco Veterans Affairs Medical CenterUniversity of California, San Francisco; Bayer Healthcare Pharmaceuticals,...UnknownHepatocellular CarcinomaUnited States
-
University of North Carolina, Chapel HillJohns Hopkins University; PENTAX of America, Inc.RecruitingBarrett Esophagus | Intestinal Metaplasia | Esophageal DysplasiaUnited States
-
Ochsner Health SystemFresenius Medical Care North America; DaVita Dialysis; Food Care, Inc.CompletedMalnutrition | End-Stage Renal DiseaseUnited States
-
Brigham and Women's HospitalKARL STORZ Endoscopy-America, Inc.; Siemens Corporation, Corporate TechnologyUnknownLymphoma | Lymphadenopathy Retroperitoneal
-
University of Kansas Medical CenterEli Lilly and Company; Kowa Pharmaceuticals America, Inc.CompletedHypercholesterolemiaUnited States
-
The University of Texas Health Science Center,...KARL STORZ Endoscopy-America, Inc.CompletedIntubation, EndotrachealUnited States
-
Milton S. Hershey Medical CenterHospice Foundation of America; John and Wauna Harman FoundationCompletedTerminal Illness | Advance Care Planning | Advance Directives | Vulnerable PopulationsUnited States
-
The Netherlands Cancer InstituteBristol-Myers Squibb; Eli Lilly and Company; Bayer; GlaxoSmithKline; Merck Sharp... and other collaboratorsRecruitingCancer | Neoplasm | Tumors | NeoplasiaNetherlands
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyNot yet recruitingOvarian CancerUnited States, Germany
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyRecruitingDermatomyositis | PolymyositisUnited States, Italy, Spain, Greece, Czechia, United Kingdom, Poland
-
Australia New Zealand Gynaecological Oncology GroupMerck Sharp & Dohme LLC; Eisai Inc.RecruitingUterine Carcinosarcoma | Ovarian CarcinosarcomaCanada, Australia, United Kingdom
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLC; BioNTech SE; Oncovir, Inc.RecruitingLymphocytic LeukemiaUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingA Study of Suboptimally Controlled Participants Previously Taking Injectable DMDs for RMS (CLICK-MS)Multiple SclerosisUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingSolid TumorsKorea, Republic of, United States, Spain, United Kingdom, Russian Federation, Argentina, Australia, Italy, Japan, Belgium, Brazil, Czechia, France, Germany, Hungary, Romania, Turkey, Bulgaria, Mexico, Poland, Thailand, Ukraine
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingSystemic Lupus ErythematosusKorea, Republic of, United States, Taiwan, China, Poland, Brazil, Argentina, Chile, Philippines, Australia, Colombia, Bulgaria, Mexico, Serbia, Greece, Spain, Israel, Japan, Mauritius, Moldova, Republic of, Romania, South Africa
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedSolid TumorsKorea, Republic of, United States, Belgium, Spain, Italy, Taiwan, Canada, Australia, United Kingdom, Germany, France, Japan
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedRelapsing-remitting Multiple SclerosisSpain, Czechia, Bulgaria, Serbia, Russian Federation, Ukraine, Poland, Slovakia
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedFirst Line Non-Small Cell Lung CancerSpain, United States, Hungary, Israel, China, Korea, Republic of, Taiwan, Czechia, Russian Federation, Australia, Brazil, Lebanon, Serbia, Thailand, Canada, Slovakia, Ukraine, Bulgaria, Italy, Netherlands, New Zealand, Poland, Belgium, Turk... and more
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedCervical CancerUnited States, Spain, Japan
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingNon-small Cell Lung CancerUnited States, Korea, Republic of, Taiwan, Spain, Hong Kong, Argentina, China, Netherlands, France, Brazil, Belgium, Canada, Germany, Greece, Italy, Japan, Turkey, Ukraine
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompleted
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminated
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedCholangiocarcinoma | Biliary Tract Cancer | Gallbladder CancerKorea, Republic of, United States, Taiwan, China, Argentina, Australia, Brazil, Chile, France, Germany, Italy, Japan, Poland, Spain, United Kingdom
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedUterine Cervical NeoplasmsKorea, Republic of, United States, France, Belgium, China, Argentina, Spain, Australia, Russian Federation, Brazil, Hungary, Japan
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; Seagen Inc.WithdrawnBrentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell LymphomaRecurrent Angioimmunoblastic T-Cell Lymphoma | Refractory Angioimmunoblastic T-Cell Lymphoma | Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified | Recurrent Enteropathy-Associated T-Cell Lymphoma | Recurrent Follicular T-Cell Lymphoma | Recurrent Hepatosplenic T-Cell Lymphoma | Recurrent... and other conditionsUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedCarcinoma, Non-Small-Cell LungUnited States, Belgium, France
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedSmall-cell Lung CancerSpain, Belgium, United States, China, Japan, Italy, France
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedLocally Advanced Rectal CancerUnited States, Spain
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompleted
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedMetastatic Renal Cell Carcinoma | Advanced Solid TumorsUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedSolid TumorsUnited States, Korea, Republic of, Taiwan, France, United Kingdom, Belgium, Czechia, Germany, Poland
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedLymphoma | Refractory or Relapsed Solid TumorsKorea, Republic of, United States, Canada, Belgium, Denmark
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedRelapsing-remitting Multiple SclerosisUnited States, Germany
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyWithdrawnBreast Cancer | Advanced Solid Tumor
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedAdvanced Solid TumorsSpain, United States, Netherlands, Hungary, Italy, France, Belgium
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedSmall Cell Lung CancerBelgium, Denmark, Italy, United States, Bulgaria, Canada, Czechia, Germany, Hungary, Poland, Romania, Spain, United Kingdom
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedCarcinoma, Non-Small-Cell LungSpain, United States, Taiwan, Belgium, Denmark, Switzerland, Argentina, Israel, Italy, Croatia, United Kingdom, Korea, Republic of, Russian Federation, Slovakia, Japan, Bulgaria, Poland, Hungary, Australia, Turkey, Peru, Chile, Mexico, Czech... and more
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedAdvanced Solid TumorUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedSystemic Sclerosis-associated Interstitial Lung DiseaseUnited States, Canada, Italy, Poland, Spain, Argentina, Australia, Israel, United Kingdom
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedRheumatoid ArthritisUnited States, Germany